IL233579A0 - Compositions comprising crosslinked cation-binding polymers and uses thereof - Google Patents
Compositions comprising crosslinked cation-binding polymers and uses thereofInfo
- Publication number
- IL233579A0 IL233579A0 IL233579A IL23357914A IL233579A0 IL 233579 A0 IL233579 A0 IL 233579A0 IL 233579 A IL233579 A IL 233579A IL 23357914 A IL23357914 A IL 23357914A IL 233579 A0 IL233579 A0 IL 233579A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- crosslinked cation
- binding polymers
- polymers
- binding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2012/020843 WO2012097011A1 (en) | 2011-01-10 | 2012-01-10 | Compositions comprising crosslinked cation- binding polymers and a base, uses thereof |
PCT/US2012/038909 WO2013106073A1 (en) | 2012-01-10 | 2012-05-21 | Compositions comprising crosslinked cation-binding polymers and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL233579A0 true IL233579A0 (en) | 2014-08-31 |
Family
ID=46210429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL233579A IL233579A0 (en) | 2012-01-10 | 2014-07-09 | Compositions comprising crosslinked cation-binding polymers and uses thereof |
Country Status (2)
Country | Link |
---|---|
IL (1) | IL233579A0 (en) |
WO (1) | WO2013106073A1 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10258698B2 (en) | 2013-03-14 | 2019-04-16 | Modernatx, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
US20160194368A1 (en) | 2013-09-03 | 2016-07-07 | Moderna Therapeutics, Inc. | Circular polynucleotides |
JP2016530294A (en) | 2013-09-03 | 2016-09-29 | モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. | Chimeric polynucleotide |
EP3052521A1 (en) | 2013-10-03 | 2016-08-10 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor |
CA2955250A1 (en) | 2014-07-16 | 2016-01-21 | Moderna Therapeutics, Inc. | Chimeric polynucleotides |
US20170210788A1 (en) | 2014-07-23 | 2017-07-27 | Modernatx, Inc. | Modified polynucleotides for the production of intrabodies |
JP7285220B2 (en) | 2017-05-18 | 2023-06-01 | モデルナティエックス インコーポレイテッド | Lipid nanoparticles comprising linked interleukin-12 (IL12) polypeptide-encoding polynucleotides |
US11485972B2 (en) | 2017-05-18 | 2022-11-01 | Modernatx, Inc. | Modified messenger RNA comprising functional RNA elements |
MA49395A (en) | 2017-06-14 | 2020-04-22 | Modernatx Inc | POLYNUCLEOTIDES COAGULATION FACTOR VIII CODING |
MA50802A (en) | 2017-11-22 | 2020-09-30 | Modernatx Inc | POLYNUCLEOTIDES CODING FOR ALPHA AND BETA SUB-UNITS OF PROPIONYL-COA CARBOXYLASE FOR THE TREATMENT OF PROPIONIC ACIDEMIA |
EP3714047A2 (en) | 2017-11-22 | 2020-09-30 | ModernaTX, Inc. | Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria |
WO2019104152A1 (en) | 2017-11-22 | 2019-05-31 | Modernatx, Inc. | Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders |
EP3735270A1 (en) | 2018-01-05 | 2020-11-11 | Modernatx, Inc. | Polynucleotides encoding anti-chikungunya virus antibodies |
US20210346306A1 (en) | 2018-05-23 | 2021-11-11 | Modernatx, Inc. | Delivery of dna |
US20220184185A1 (en) | 2018-07-25 | 2022-06-16 | Modernatx, Inc. | Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders |
EP3846776A1 (en) | 2018-09-02 | 2021-07-14 | ModernaTX, Inc. | Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiency |
MA53608A (en) | 2018-09-13 | 2021-07-21 | Modernatx Inc | POLYNUCLEOTIDES ENCODED FOR THE E1-ALPHA, E1-BETA AND E2 SUBUNITS OF THE BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE COMPLEX FOR THE TREATMENT OF LEUCINOSIS |
JP2022500436A (en) | 2018-09-13 | 2022-01-04 | モダーナティエックス・インコーポレイテッドModernaTX, Inc. | Polynucleotide encoding glucose-6-phosphatase for treating glycogen storage disease |
AU2019339430A1 (en) | 2018-09-14 | 2021-04-29 | Modernatx, Inc. | Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide A1 for the treatment of Crigler-Najjar Syndrome |
US20220152225A1 (en) | 2018-09-27 | 2022-05-19 | Modernatx, Inc. | Polynucleotides encoding arginase 1 for the treatment of arginase deficiency |
WO2020227642A1 (en) | 2019-05-08 | 2020-11-12 | Modernatx, Inc. | Compositions for skin and wounds and methods of use thereof |
JP2023527875A (en) | 2020-06-01 | 2023-06-30 | モダーナティエックス・インコーポレイテッド | Phenylalanine hydroxylase variants and uses thereof |
CA3199784A1 (en) | 2020-11-13 | 2022-05-19 | Modernatx, Inc. | Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis |
EP4314260A1 (en) | 2021-03-24 | 2024-02-07 | Modernatx, Inc. | Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency |
US20240216288A1 (en) | 2021-03-24 | 2024-07-04 | Modernatx, Inc. | Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof |
WO2022204390A1 (en) | 2021-03-24 | 2022-09-29 | Modernatx, Inc. | Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof |
WO2022204369A1 (en) | 2021-03-24 | 2022-09-29 | Modernatx, Inc. | Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia |
WO2022204371A1 (en) | 2021-03-24 | 2022-09-29 | Modernatx, Inc. | Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof |
EP4355882A2 (en) | 2021-06-15 | 2024-04-24 | Modernatx, Inc. | Engineered polynucleotides for cell-type or microenvironment-specific expression |
WO2022271776A1 (en) | 2021-06-22 | 2022-12-29 | Modernatx, Inc. | Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome |
EP4408871A1 (en) | 2021-10-01 | 2024-08-07 | ModernaTX, Inc. | Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease |
WO2023183909A2 (en) | 2022-03-25 | 2023-09-28 | Modernatx, Inc. | Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia |
TW202412818A (en) | 2022-07-26 | 2024-04-01 | 美商現代公司 | Engineered polynucleotides for temporal control of expression |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4944389B1 (en) * | 1970-12-18 | 1974-11-28 | ||
EP1847271A3 (en) * | 2000-11-20 | 2008-08-06 | Sorbent Therapeutics, Inc. | Water-absorbent polymers and their use as a medicament |
US7223827B1 (en) * | 2004-02-27 | 2007-05-29 | Fritz Industries, Inc | Water control in a subsurface formation |
WO2009029841A1 (en) * | 2007-08-29 | 2009-03-05 | Sorbent Therapeutics, Inc. | Absorbent polymeric compositions with varying counterion content and their methods of preparation and use |
-
2012
- 2012-05-21 WO PCT/US2012/038909 patent/WO2013106073A1/en active Application Filing
-
2014
- 2014-07-09 IL IL233579A patent/IL233579A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2013106073A1 (en) | 2013-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL233578A0 (en) | Compositions comprising crosslinked cation-binding polymers and uses thereof | |
IL233579A0 (en) | Compositions comprising crosslinked cation-binding polymers and uses thereof | |
HK1203420A1 (en) | Compositions comprising crosslinked cation-binding polymers | |
HK1203449A1 (en) | Azetidinium-containing copolymers and uses thereof | |
EP2914239A4 (en) | Composition comprising conditioning and/or styling polymer | |
SG11201501467WA (en) | Ethylene-based polymer compositions and foams | |
EP2608767A4 (en) | Polymer compositions and methods | |
PL2660285T3 (en) | Rubber composition and crosslinked rubber product | |
EP2927281A4 (en) | Resin composition and use thereof | |
PT3080176T (en) | Multistage polymers and compositions thereof | |
EP2921506A4 (en) | Modified polymer | |
GB201223369D0 (en) | Polymer and device | |
EP2714023A4 (en) | Crosslinked polymer nano-assemblies and uses thereof | |
HK1205166A1 (en) | Polymer, composition and use | |
SG11201405575YA (en) | Modified polymer compositions | |
EP2890774A4 (en) | Carboxyl group-containing polymer and composition containing the same | |
HK1212601A1 (en) | Compositions comprising vortioxetine and donepezil | |
SG10201709919RA (en) | Polymer compositions and nonwoven compositions prepared therefrom | |
SG11201501661YA (en) | Polymer composition | |
IL227389A0 (en) | Compositions comprising crosslinked cation-binding polymers and a base, uses thereof | |
EP2938348A4 (en) | Alginate compositions and uses thereof | |
HK1244518A1 (en) | Compositions comprising a polymer-protein conjugate and an environmentally-responsive polymer and uses thereof | |
EP2874641A4 (en) | Glutathione-elevating compositions and uses thereof | |
GB201218637D0 (en) | Biodegradable polymer blend | |
EP2735581A4 (en) | Composition and polymer |